Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.3, replacing the previous v3.6.2. This indicates a minor metadata/format update to the page rather than a substantive change to content.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a refreshed or corrected version of the study record.
    Difference
    0.1%
    Check dated 2026-06-26T19:38:14.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now lists the investigator and sponsor names as additions and adds several navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated label (Intervention/Treatment) and a new revision tag (Revision: v3.6.0). It also removes older labels and references (Last known status was, Verified) and the prior version tag (Revision: v3.5.5).
    Difference
    1%
    Check dated 2026-06-12T12:37:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision changed from v3.5.4 to v3.5.5, indicating a new version of the page. This is a metadata update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T08:25:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.3 to v3.5.4, signaling a new build deployment. This update does not modify the study content or essential information on the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:59:11.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Version label updated from v3.5.2 to v3.5.3, signaling a new release of the page interface. The update does not modify the study content or data.
    Difference
    0.1%
    Check dated 2026-04-30T18:09:52.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.